ADMA Biologics Inc (ADMA): Price and Financial Metrics
ADMA Biologics Inc (ADMA)
Today's Latest Price: $2.37 USD
Updated Jan 27 9:14am
Add ADMA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ADMA Stock Summary
- With a price/sales ratio of 5.77, Adma Biologics Inc has a higher such ratio than 73.74% of stocks in our set.
- Revenue growth over the past 12 months for Adma Biologics Inc comes in at 88.6%, a number that bests 93.94% of the US stocks we're tracking.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ADMA comes in at -48.08% -- higher than that of merely 6.06% of stocks in our set.
- Stocks that are quantitatively similar to ADMA, based on their financial statements, market capitalization, and price volatility, are CPST, NXTD, ENVA, SWM, and TTMI.
- Visit ADMA's SEC page to see the company's official filings. To visit the company's web site, go to www.admabiologics.com.
ADMA Stock Price Chart Interactive Chart >
ADMA Price/Volume Stats
Current price | $2.37 | 52-week high | $4.25 |
Prev. close | $2.46 | 52-week low | $1.45 |
Day low | $2.37 | Volume | 116,321 |
Day high | $2.37 | Avg. volume | 3,792,654 |
50-day MA | $2.08 | Dividend yield | N/A |
200-day MA | $2.53 | Market Cap | 224.08M |
ADMA Biologics Inc (ADMA) Company Bio
ADMA Biologics, Inc. develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The company was founded in 2004 and is based in Ramsey, New Jersey.
Loading social stream, please wait...